A legacy alcohol powerhouse is testing its instincts in a market that rewards nerve, timing, and a willingness to unlearn the old rules. Known for Samuel Adams beer, Twisted Tea, Angry Orchard cider and Truly hard seltzer, the storied Boston Beer Company has applied decades of beverage expertise to a market that is both nascent and notoriously complex.
What began with tea has expanded into cocktails and gummies, all within a regulatory environment that demands nimble thinking and fresh technological approaches.
A Legacy of Liquid Meets New Plant Science
Boston Beer’s foray into cannabis stems from a bet on demand for non-alcohol alternatives that still deliver an adult experience. The company established a Canadian research and development subsidiary in 2021 to focus on non-alcoholic cannabis beverages, a decision that married its heritage of liquid formulation with the plant’s unique challenges.
Paul Weaver, the company’s director and head of cannabis, described a career path from Molson Coors, through Canopy Growth, to Boston Beer, a transition fueled by a fascination with craft beverages and the complexities of cannabis infusion.
“I learned… not just about the industry, but also cultivation and how to grow weed and different form factors extraction,” he told Cannabis & Tech Today.
Those early lessons in how to make a cannabis beverage “and how delicate and difficult that process is” set the stage for the Boston Beer team’s work.
Infusing THC into water-based drinks remains technically demanding. Unlike alcohol, cannabis compounds do not mix naturally with water, requiring advanced techniques to disperse cannabinoids without sacrificing flavor or mouthfeel.
Boston Beer’s products are non-carbonated and free of bubbles, a choice that enhances drinkability yet presents significant engineering hurdles. Weaver credited his team’s beverage-making expertise, accrued over decades, with solving such issues.
“Our company has so many super smart people that make amazing beverages… we have this body of knowledge,” he said.
TeaPot and the Science of Subtlety
Boston Beer’s first cannabis-infused product was TeaPot, a line of iced teas combining real tea with premium cannabis extracts. Launched in Canada in 2022, TeaPot quickly expanded its lineup and dosing options, introducing higher-potency variants like rosined-infused versions with 10 milligrams of THC per can.
The philosophy behind TeaPot strikes an intentional balance. These beverages avoid overt cannabis taste and aroma, instead pairing classic tea profiles with selective strains to evoke particular occasions, whether a sunny afternoon or a relaxing evening.
Weaver highlighted the importance of simplicity and accessibility: a five milligram lemon black tea variant was designed as “a better tasting non-alcoholic version of Twisted Tea,” aiming to be “sessionable” and approachable for consumers who may be new to cannabis.
This attention to taste and texture is more than aesthetic. In a market crowded with novelty products and idiosyncratic formulations, consumers consistently reward quality that feels familiar and refined. Weaver observed that if a product “just tastes better than everyone else, you’ll find success.”
Technology and Trust
One of the biggest hurdles in cannabis beverages is not just getting the formulation right, but navigating a regulatory maze that shifts by state, by agency, and sometimes by the week.
Unlike alcoholic drinks, THC products move through a far tighter system of licensing and distribution, one shaped by patchwork laws and compliance demands that leave little room for improvisation. Boston Beer’s cannabis subsidiary is set up as a distinct business unit to meet these requirements, adjusting everything from banking relationships to insurance coverage to ensure compliance. Weaver described this groundwork as less glamorous than product design but critical to viable operation.
Innovation also reveals itself in the way cannabinoids are worked into these products, where chemistry, consumer expectation, and hard regulatory limits all collide in the glass. Many of Boston Beer’s beverages and edibles use solventless extracts, such as live rosin and full-spectrum cannabis diamonds. These techniques avoid chemical solvents, creating a “cleaner” infusion that appeals to consumers wary of additives.
Emerald Hour and Premium Positioning
Emerald Hour represents Boston Beer’s next chapter in cannabis edibles and drinks. Originally launched as a line of non-alcoholic, rosin-infused cannabis cocktails, the brand has rapidly expanded both product types and geographic reach within Canada.
These “Cali Sober” cocktails, with 10 milligrams of THC each, are designed as elevated alternatives to traditional happy hour beverages, blending real cocktail ingredients with cannabis extracts in a way meant to satisfy discerning adult consumers seeking sophistication rather than gimmick. That same ethos carries into Emerald Hour’s gummies: pocket-friendly packs infused with solventless cannabis diamonds and live rosin, targeting a premium edible experience.
Weaver frames the expansion as a calculated play, aimed at competing not only on dispensary shelves but across the wider landscape of adult consumption, where habits are shifting and traditional categories are starting to blur. He noted that while edible gummies account for a sizable share of dispensary sales, the category is plagued by commoditization. Boston Beer’s response has been to push hard on taste, dosing precision, and packaging, shaping a product meant to stand on its own not just through intoxication, but on sensory appeal and brand credibility.
Culture Clash and Consumer Expectations
Transitioning a legacy brewer into cannabis has not been without cultural friction. In cannabis circles, big established companies can be met with skepticism, particularly when they enter an industry shaped by grassroots culture and a legacy market that predates legalization. Weaver acknowledged this tension, emphasizing Boston Beer’s efforts to respect the industry’s roots, from charitable work to building trust rather than relying on brand prestige alone.
That sensitivity points to a larger truth about cannabis innovation. Technology and brand equity might get a company in the door, but authenticity and real community engagement are what keep it there. For many consumers, cannabis is an intimate choice, shaped as much by aesthetics, ritual, and trust as by the effects themselves.
